Purchase Order HHSN268201600244A
Award Date 8/19/16
Potential Completion Date 8/18/17
Potential Value $81K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Bethesda, MD 20852, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $646,396.36 and no set-aside designation. Illumina, a manufacturer of sequencing and array-based genomic analysis solutions, will provide a range of sequencing systems, reagents, and services to support NHLBI's research and diagnostics needs. Illumina has a history of...
- This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of sequencing services. The contract has a ceiling value of $95,569.54 and does not include any set-aside provisions. Illumina, a manufacturer of genetic analysis instruments and reagents, has previously received prime federal contracts and grants from agencies including the NIH, Centers...
- This is a firm fixed price delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the provision of laboratory equipment and supplies, specifically Illumina's genetic sequencing systems and related consumables. The contract has a total ceiling value of $84,812.59 and a period of performance through September 2, 2020. There is no set-aside designation for this award. Illumina has...
- This is a firm fixed-price delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The $48,994.05 contract is for the procurement of an Illumina MiSeq I100 sequencing system and associated reagents and services, to support high-quality DNA sequencing and genomic research at NHLBI. The contract has an ultimate...
- This is a firm fixed price delivery order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The purpose of the contract is to provide Illumina kits and reagents to support next-generation sequencing on Illumina instruments for NHLBI's Sequencing Core Facility. The contract has a ceiling value of $91,959.00 and a period of performance through September 2, 2025. This contract was not set aside for...
- This is a $303,238.66 firm fixed price delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the provision of various Illumina sequencing systems, reagents, and consumables to support genomic sequencing and analysis for research and diagnostic purposes. Illumina is the sole manufacturer of the specified sequencing platforms. This award is part of a larger Indefinite...
- This is a firm fixed price delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the procurement of Illumina sequencing kits and reagents to support next-generation sequencing work conducted by the NHLBI Sequencing Core Facility. The total ceiling value of the order is $81,529.98, with a period of performance through June 7, 2023. There is no set-aside designation for this...
- This is a firm fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $383,592.54 contract is for the provision of various Illumina sequencing systems, reagents, consumables, and related services to support genomic sequencing and analysis. The award is not set aside and was made on a sole-source basis, with Illumina identified as the sole manufacturer of the required sequencing...
- This is a firm fixed-price delivery order awarded by the National Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian federal agency. The $42,511.56 contract is for Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, to provide Illumina sequencing kits and reagents to support next-generation DNA sequencing activities at the NHLBI Sequencing Core Facility. The contract has a performance period ending on...
- This is a firm fixed price delivery order contract awarded by the National Institutes of Health (NIH) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract has a ceiling value of $16,648.41 and a performance period extending through June 8, 2025. Illumina will provide a range of genomic sequencing platforms, reagents, consumables, maintenance services, and technical support to the NIH. This includes the procurement of NextSeq, NovaSeq,...